FDA Inspection 1097014 — Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd. — FEI 3002808385

The FDA completed an inspection of Taro Pharmaceutical Industries Ltd. on Jul 11, 2019 in Haifa Bay. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 11, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Haifa Bay (Israel)

Citations

IDCFRDescription
202821 CFR 211.192Extent of discrepancy, failure investigations

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.